ALAdriana Lofrano-Porto

Adriana Lofrano-Porto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adriana Lofrano-Porto has a total of 162 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gender-Affirming Hormone Therapy in transgender women athletes: a review highlighting the need for predictive animal models

    by Ariane Bocaletto Frare, Ana Beatriz da Silva Sousa, Daniel Rodrigues Ferreira Saint-Martin, Guilherme Rodrigues Vieira, Kevin Alves Barreto, Adriana Lofrano Alves Porto, Francisco de Assis Rocha Neves, Alexandre de Góes Martini

    The inclusion of transgender women in women’s sports has raised a complex debate encompassing scientific, ethical, and legal dimensions, mainly due to the tension between inclusivity and competitive fairness. Physiological differences between sexes, particularly those derived from post-pubertal testosterone exposure, provide individuals assigned male at birth with advantages in muscle mass, strength, and cardiorespiratory capacity. This study aims to review current evidence regarding the impact of Gender-Affirming Hormone Therapy (GAHT) on the athletic performance of transgender women and to highlight the necessity of developing predictive animal models for deeper mechanistic understanding. A narrative review of recent literature was conducted, focusing on studies involving both human subjects and animal models that simulate GAHT. Rodent models, such as Sprague-Dawley rats and C57BL/6J mice, have been explored to evaluate changes in body composition, bone health, cardiovascular risk, and reproductive function under controlled hormonal manipulation. The analysis reveals that while GAHT can partially reduce physiological advantages, certain performance-related parameters may persist beyond hormone suppression periods. In conclusion, the lack of an ideal in vivo model capable of fully reproducing the physiological adaptations of endurance athletes reinforces the urgent need for optimized and ethically validated animal models. Such models will help fill critical knowledge gaps and support the formulation of fair and evidence-based policies for transgender inclusion in competitive sports.


  • Open Access

    Musculoskeletal, Pulmonary, and Cardiovascular COVID-19 Sequelae in the Context of Firefighter Occupational Health: A Narrative Review

    by Elliot L. Graham, Susanne D’isabel, Adriana Lofrano-Porto, Denise L. Smith

    For most individuals infected with SARS-CoV-2, the acute illness resolves completely. However, for millions of people, symptoms or sequelae from COVID-19 recur or persist for months to years after infection. Post-COVID-19 sequelae are wide-ranging, often affecting the musculoskeletal, pulmonary, and cardiovascular systems. All who experience post-COVID-19 sequelae face significant challenges navigating home and work life. Occupations such as firefighting, however, are of particular concern given the strenuous nature of a job that relies on a healthy musculoskeletal, pulmonary, and cardiovascular system. Research has documented significant musculoskeletal impairment (including muscle weakness, pain, and fatigue), respiratory dysfunction (including reduced lung function, interstitial disease, and diffusion abnormalities), cardiovascular conditions (including cardiac events, ischemic disease, dysrhythmias, and infectious diseases), and diminished cardiorespiratory fitness that continues for months to years in some individuals. These persistent post-COVID-19 conditions may affect a firefighter’s ability to return to work, function at full capacity while at work, and potentially compromise firefighter health and public safety. This review, therefore, explores musculoskeletal, pulmonary, and cardiovascular sequelae post-COVID-19 and the impact of these sequelae on firefighter health and occupational readiness.


  • Open Access

    Association of Endogenous Testosterone with Physical Fitness Measures during Firefighter Occupational Health Evaluations

    by Luiz Guilherme Grossi Porto, Edgard M. K. V. K. Soares, Sushant M. Ranadive, Adriana Lofrano-Porto, Denise L. Smith

    Firefighting is a physically demanding profession associated with unacceptably high on-duty cardiovascular mortality. Low endogenous total testosterone (TT) is an emerging cardiometabolic (CM) risk factor in men, but limited data exists on its interactions with physical fitness (PF). Data from occupational health and fitness assessments of 301 male career firefighters (FFs) were analyzed. TT was categorized as low (<264 ng/dL), borderline (264–399 ng/dL), and reference (400–916 ng/dL). PF tests included cardiorespiratory fitness (submaximal treadmill), body fat percentage (BF%), push-ups, plank, and handgrip strength assessments. In the crude analyses, FFs in the low TT group had worse muscular and cardiorespiratory fitness measures compared to the referent group. However, after adjusting for age and BF%, none of the PF differences remained statistically significant. Similarly, the odds of less-fit FFs (PF performance below median values) having low TT were higher compared to the fitter ones only before adjusting for age and BF%. Therefore, in the final adjusted model, there was no significant association between TT and PF. Our data suggest that age and body fat confound the association between PF and TT. Low TT and poor PF are important components of FFs’ CM risk profile, and there is potential benefit to considering TT screening as part of a comprehensive occupational health program that manages performing medical evaluations and provides education and preventative programming.


  • Open Access

    OSR1 disruption contributes to uterine factor infertility via impaired Müllerian duct development and endometrial receptivity

    by Adriana Lofrano-Porto, Sidney Alcântara Pereira, Andrew Dauber, Jordana C.B. Bloom, Audrey N. Fontes, Naomi Asimow, Olívia Laquis de Moraes, Petra Ariadne T. Araujo, Ana Paula Abreu, Michael H. Guo, et al.

    Three sisters, born from consanguineous parents, manifested a unique Müllerian anomaly characterized by uterine hypoplasia with thin estrogen-unresponsive endometrium and primary amenorrhea, but with spontaneous tubal pregnancies. Through whole-exome sequencing followed by comprehensive genetic analysis, a missense variant was identified in the OSR1 gene. We therefore investigated OSR1/OSR1 expression in postpubertal human uteri, and the prenatal and postnatal expression pattern of Osr1/Osr1 in murine developing Müllerian ducts (MDs) and endometrium, respectively. We then investigated whether Osr1 deletion would affect MD development, using WT and genetically engineered mice. Human uterine OSR1/OSR1 expression was found primarily in the endometrium. Mouse Osr1 was expressed prenatally in MDs and Wolffian ducts (WDs), from rostral to caudal segments, in E13.5 embryos. MDs and WDs were absent on the left side and MDs were rostrally truncated on the right side of E13.5 Osr1–/– embryos. Postnatally, Osr1 was expressed in mouse uteri throughout their lifespan, peaking at postnatal days 14 and 28. Osr1 protein was present primarily in uterine luminal and glandular epithelial cells and in the epithelial cells of mouse oviducts. Through this translational approach, we demonstrated that OSR1 in humans and mice is important for MD development and endometrial receptivity and may be implicated in uterine factor infertility.


  • Effects of medicinal plants and natural compounds in models of prostate cancer related to sex steroids: A systematic review

    by Rafael Abe da Rocha Miranda, Marcela Martins de Paula Oliveira, Maria Isadora Gabriel Sampaio, João Victor Dutra Gomes, Damaris Silveira, Eliete Neves Silva Guerra, Adriana Lofrano‐Porto, Cinthia Gabriel Meireles, Luiz Alberto Simeoni

    Prostate cancer remains a health problem for men. Targeting androgen (AR) and estrogen (ER) receptors improves the outcomes of the disease, and many medicinal plants exert their effects by modulating these pathways. Therefore, a systematic review was conducted to identify medicinal plants and their natural compounds that may modulate the AR and/or ER pathways in cell and animal models. A search was conducted across EMBASE, LILACS, PubMed, Scopus, and Web of Science, with grey literature from Google SCHOLAR and ProQuest. Two authors independently selected eligible studies based on their titles and abstracts, and a third author resolved conflicts. Then, data from the full text of eligible studies were extracted and synthesized. In total, 75 studies were included. Results showed the effects of several different medicinal plants and natural compounds in reduction of AR and/or ER transcription and translation and AR secondary effects: cell growth reduction, induction of apoptosis, and cell cycle arrest. In animal models, tumor size reduction, increase in apoptosis, and downregulation of AR expression in tumors were also observed. No single phytochemical group concentrating molecules with anti‐AR and/or ER activity was identified. Nevertheless, several phytochemical compounds showed potential for future clinical studies in the management of the disease.


  • Open Access

    Author Correction: Low testosterone and cardiometabolic risks in a real-world study of US male firefighters

    by Sushant M. Ranadive, Adriana Lofrano‑Porto, Edgard M. K. V. K. Soares, Lauren Eagan, Luiz Guilherme Grossi Porto, Denise L. Smith

  • Antiproliferative effects of metformin in cellular models of pheochromocytoma

    by Cinthia Gabriel Meireles, Caroline Lourenço de Lima, Marcela Martins de Paula Oliveira, Rafael Abe da Rocha Miranda, Lisa Romano, Teisha Yo-Stella Brashaw, Eliete Neves da Silva Guerra, Francisco de Assis Rocha Neves, J. Paul Chapple, Luiz Alberto Simeoni, et al.


  • Open Access

    Low testosterone and cardiometabolic risks in a real-world study of US male firefighters

    by Sushant M. Ranadive, Adriana Lofrano-Porto, Edgard M. K. V. K. Soares, Lauren Eagan, Luiz Guilherme Grossi Porto, Denise L. Smith

    Low serum total testosterone (TT) is associated with increased cardiovascular risk and metabolic derangements, with fatty liver (FL) emerging as an additional cardiometabolic threat. We investigated the associations between TT and cardiometabolic (CM) health in 298 US male firefighters. Cross-sectional data from occupational health examination were analyzed. TT was categorized as low (< 264 ng/dL), borderline (264–399 ng/dL), and reference (400–916 ng/dL). Conventional CM risk factors were compared among TT categories, and between firefighters with and without FL. 81% of firefighters were obese/overweight; almost 40% had FL. In the low-TT group, only 3.1% had normal BMI, while 78.1% had FL. The low-TT group had a worse CM profile, independently of age and BMI, and a fourfold higher adjusted odds of having FL. FL was associated with lower TT, regardless of age, BMI and HbA1c. Having a FL, HbA1c ≥ 5.7% or triglycerides ≥ 150 mg/dL increased the odds for low-TT by 4.1, 2.7 and 6.6 times, respectively. These real-world data reveal strong associations between low-TT and CM risk factors and support a call for action towards screening for low-TT and FL, regardless of age, BMI or dysmetabolic conditions in firefighters. Recognizing cardiometabolic risks in firefighters provides an opportunity to lessen cardiovascular diseases burden.


  • Open Access

    Borderline‐low testosterone levels are associated with lower left ventricular wall thickness in firefighters: An exploratory analysis

    by Adriana Lofrano‐Porto, Edgard M. K. V. K. Soares, Alexs Mattias, Luiz Guilherme Grossi Porto, Denise L. Smith

    Background Low endogenous testosterone has been associated with increased cardiovascular risk in men. Objectives To determine the prevalence of low serum testosterone level (TT) in a cohort of male US career firefighters and to examine its relation with left ventricular wall thickness (LVWT). Material and Methods We conducted a cross‐sectional study among 341 career firefighters, (age:37.5±10.3 years; BMI:28.9±4.5 kg/m2), who underwent an occupational medical screening examination. TT quartiles were determined and LVWT distribution among them were plotted. Then, TT values were categorized as low (916 ng/dL). To further investigate the association of mildly decreased TT on LVWT, we divided the borderline group into borderline‐low (264‐319 ng/dL) and borderline‐high (320‐399 ng/dL) ranges. LVWT values were classified as low‐LVWT when <0.6 cm. A multivariate model was used to compare LVWT, age, BMI, systolic blood pressure (SBP) and HbA1c among groups by TT values. Results The prevalence of low TT was 10.6%, and borderline was 26.4%, while 58.7% had levels in the reference range. The low‐TT group was older, had higher BMI and SBP as compared to the reference group (p<0.01). LVWT values were different among groups (p=0.04) and significantly lower in firefighters with borderline‐low TT as compared to the reference group (p<0.05). This finding also occurred within obese firefighters (p=0.03). The borderline‐low group had a higher adjusted risk for a low‐LVWT as compared to the reference group [OR:4.11(95%CI:1.79–9.43)]. Discussion Our findings highlight the possible relationship between a mild reduction in testosterone levels (borderline) and lower LVWT. Conclusions A high prevalence of subnormal TT levels (low and borderline: 37%) was observed in this relatively homogeneous cohort of career firefighters. Mildly decreased TT levels and lower LVWT might represent a preclinical condition and a window of opportunity for cardiovascular preventive interventions in firefighters.


  • Open Access

    MKRN3 Mutations in Central Precocious Puberty: A Systematic Review and Meta-Analysis

    by Luciana Pinto Valadares, Cinthia Gabriel Meireles, Isabela Porto De Toledo, Renata Santarem de Oliveira, Luiz Cláudio Gonçalves de Castro, Ana Paula Abreu, Rona S Carroll, Ana Claudia Latronico, Ursula B Kaiser, Eliete Neves Silva Guerra, et al.

    MKRN3 mutations represent the most common genetic cause of central precocious puberty (CPP) but associations between genotype and clinical features have not been extensively explored. This systematic review and meta-analysis investigated genotype-phenotype associations and prevalence of MKRN3 mutations in CPP. The search was conducted in seven electronic databases (Cochrane, EMBASE, LILACS, LIVIVO, PubMed, Scopus and Web of Science) for articles published until September 4, 2018. Studies evaluating MKRN3 mutations in patients with CPP were considered eligible. A total of 22 studies, studying 880 subjects with CPP, fulfilled the inclusion criteria. 89 subjects (76 girls) were identified as harboring MKRN3 mutations. Girls, compared to boys, exhibited earlier age at pubertal onset (median 6.0 years, range 3.0-7.0, vs 8.5 years, range 5.9-9.0, Pvs 2.45 IU/L, range 0.8-13.70 IU/L, P=0.003), and bone age advancement (median 2.3 years, range -0.9-5.2 vs 1.2 years, range 0.0-2.3, P=0.01). Additional dysmorphisms were uncommon. A total of 14 studies evaluating 857 patients were included for quantitative analysis, with a pooled overall mutation prevalence of 9.0% (95% CI 0.04-0.15). Subgroup analysis showed that prevalence estimates were higher in males, familial cases and in non-Asian countries. In conclusion, MKRN3 mutations are associated with non-syndromic CPP and manifest in a gender-dimorphic manner, with girls being affected earlier. They represent a common cause of CPP in western countries, especially in boys and familial cases.